Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (151-160 of 263) with videos related to

Pageof 27
Sort By:
NPJ Vaccines|April 6, 2018
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of <i>M. leprae</i> infectionMalcolm S Duthie, Maria T Pena, Gigi J Ebenezer, et al.
Frontiers in Microbiology|September 12, 2022
Therapeutic efficacy against <i>Mycobacterium tuberculosis</i> using ID93 and liposomal adjuvant formulationsSusan L Baldwin, Valerie A Reese, Sasha E Larsen, et al.
European Journal of Immunology|November 5, 2014
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γAnthony L Desbien, Steven J Reed, Hilton R Bailor, et al.
Infection and Immunity|August 29, 2007
Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse earMalcolm S Duthie, Stephen T Reece, Ramanuj Lahiri, et al.
Vaccines|January 21, 2023
An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i>Sasha E Larsen, Jesse H Erasmus, Valerie A Reese, et al.
Plos Neglected Tropical Diseases|April 18, 2012
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqiRegis Gomes, Clarissa Teixeira, Fabiano Oliveira, et al.
Vaccine|March 24, 2016
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain KSeung Bin Cha, Woo Sik Kim, Jong-Seok Kim, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccineZachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
Colloids and Surfaces. B, Biointerfaces|September 15, 2009
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulationsRyan C Anderson, Christopher B Fox, Timothy S Dutill, et al.
Vaccine|March 20, 2016
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigenSusan L Baldwin, Will Roeffen, Susheel K Singh, et al.
Pageof 27

Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
NPJ Vaccines|April 6, 2018
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of <i>M. leprae</i> infectionMalcolm S Duthie, Maria T Pena, Gigi J Ebenezer, et al.
Frontiers in Microbiology|September 12, 2022
Therapeutic efficacy against <i>Mycobacterium tuberculosis</i> using ID93 and liposomal adjuvant formulationsSusan L Baldwin, Valerie A Reese, Sasha E Larsen, et al.
European Journal of Immunology|November 5, 2014
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γAnthony L Desbien, Steven J Reed, Hilton R Bailor, et al.
Infection and Immunity|August 29, 2007
Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse earMalcolm S Duthie, Stephen T Reece, Ramanuj Lahiri, et al.
Vaccines|January 21, 2023
An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i>Sasha E Larsen, Jesse H Erasmus, Valerie A Reese, et al.
Plos Neglected Tropical Diseases|April 18, 2012
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqiRegis Gomes, Clarissa Teixeira, Fabiano Oliveira, et al.
Vaccine|March 24, 2016
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain KSeung Bin Cha, Woo Sik Kim, Jong-Seok Kim, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccineZachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
Colloids and Surfaces. B, Biointerfaces|September 15, 2009
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulationsRyan C Anderson, Christopher B Fox, Timothy S Dutill, et al.
Vaccine|March 20, 2016
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigenSusan L Baldwin, Will Roeffen, Susheel K Singh, et al.
Pageof 27